These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31232967)

  • 1. Association between TP53 gene codon72 polymorphism and prostate cancer risk: A systematic review and meta-analysis.
    Han PZ; Cao DH; Zhang XL; Ren ZJ; Wei Q
    Medicine (Baltimore); 2019 Jun; 98(25):e16135. PubMed ID: 31232967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and risk of glioma.
    Zhang F; Li D; Li Y; Li H; Sun J; Li X; Li X
    Tumour Biol; 2014 Jan; 35(1):747-51. PubMed ID: 24046089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between codon72 polymorphism of p53 gene and the risk of endometrial cancer: an updating meta-analysis.
    Lin X; Hou D; Huang C; Luo X
    Arch Gynecol Obstet; 2016 Aug; 294(2):353-9. PubMed ID: 26749437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between the TP53 codon 72 polymorphism and risk of oral squamous cell carcinoma in Asians: a meta-analysis.
    Zeng XT; Luo W; Geng PL; Guo Y; Niu YM; Leng WD
    BMC Cancer; 2014 Jun; 14():469. PubMed ID: 24969046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and bladder cancer risk.
    Liu ZH; Bao ED
    Mol Biol Rep; 2013 Mar; 40(3):2389-95. PubMed ID: 23184052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of p53 codon72 Arg>Pro polymorphism with susceptibility to nasopharyngeal carcinoma: evidence from a case-control study and meta-analysis.
    Sahu SK; Chakrabarti S; Roy SD; Baishya N; Reddy RR; Suklabaidya S; Kumar A; Mohanty S; Maji S; Suryanwanshi A; Rajasubramaniam S; Asthana M; Panda AK; Singh SP; Ganguly S; Shaw OP; Bichhwalia AK; Sahoo PK; Chattopadhyay NR; Chatterjee K; Kundu CN; Das AK; Kannan R; Zorenpuii ; Zomawia E; Sema SA; Singh YI; Ghosh SK; Sharma K; Das BS; Choudhuri T
    Oncogenesis; 2016 May; 5(5):e225. PubMed ID: 27159678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between p53 Arg72Pro polymorphism and thyroid cancer risk: a meta-analysis.
    Wu B; Guo D; Guo Y
    Tumour Biol; 2014 Jan; 35(1):561-5. PubMed ID: 24037912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between the p53 codon 72 Arg/Pro polymorphism and hepatocellular carcinoma risk.
    Lv L; Wang P; Zhou X; Sun B
    Tumour Biol; 2013 Jun; 34(3):1451-9. PubMed ID: 23564481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between TP53 Arg72Pro polymorphism and thyroid carcinoma risk.
    Wang F; Wang P; Wang B; Fu ZJ; Yuan Y; Yan SL; Zhao WJ; Wang YG
    Tumour Biol; 2014 Mar; 35(3):2723-8. PubMed ID: 24375191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53 gene Arg72Pro polymorphism and male infertility risk: A meta-analysis.
    Ren ZJ; Zhang Q; Ren PW; Yang B; Liu SZ; Liao J; Yang LC; Lu DL; Liu LR; Dong Q
    Andrologia; 2018 Dec; 50(10):e13122. PubMed ID: 30155914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between TP53 Arg72Pro polymorphism and hepatocellular carcinoma risk: a meta-analysis.
    Xu CT; Zheng F; Dai X; Du JD; Liu HR; Zhao L; Li WM
    Asian Pac J Cancer Prev; 2012; 13(9):4305-9. PubMed ID: 23167333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis.
    Jiang DK; Yao L; Ren WH; Wang WZ; Peng B; Yu L
    Med Oncol; 2011 Dec; 28(4):1129-35. PubMed ID: 20552298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between polymorphism of P53 Codon72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3,704 cases.
    Hu S; Zhao L; Yang J; Hu M
    Tumour Biol; 2014 Apr; 35(4):3647-56. PubMed ID: 24326769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of TP53 codon 72 with prostate carcinoma risk: a meta-analysis.
    Zhang J; Zhuo WL; Zheng Y; Zhang YS
    Med Oncol; 2010 Jun; 27(2):540-6. PubMed ID: 19499352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between p53 polymorphism at codon 72 and recurrent spontaneous abortion.
    Zhang Y; Wu YY; Qiao FY; Zeng WJ
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):402-405. PubMed ID: 27376811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the P53 codon 72 polymorphism and nasopharyngeal cancer risk.
    Cai K; Wang Y; Zhao X; Bao X
    Tumour Biol; 2014 Mar; 35(3):1891-7. PubMed ID: 24114013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between P53 Arg72Pro and development of digestive tract cancers: a meta-analysis.
    Liu L; Wang K; Zhu ZM; Shao JH
    Arch Med Res; 2011 Jan; 42(1):60-9. PubMed ID: 21376265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of p53 codon 72 polymorphism with prostate cancer: an update meta-analysis.
    Lu Y; Liu Y; Zeng J; He Y; Peng Q; Deng Y; Wang J; Xie L; Li T; Qin X; Li S
    Tumour Biol; 2014 May; 35(5):3997-4005. PubMed ID: 24488627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysis.
    Jiang DK; Yao L; Wang WZ; Peng B; Ren WH; Yang XM; Yu L
    World J Gastroenterol; 2011 Mar; 17(9):1227-33. PubMed ID: 21448430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of TP53 Gene Codon 72 Polymorphism in Leukemia: A PRISMA-Compliant Systematic Review and Meta-Analysis.
    Ruan XL; Li S; Meng XY; Geng P; Gao QP; Ao XB
    Medicine (Baltimore); 2015 Sep; 94(38):e1588. PubMed ID: 26402821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.